Facebook
X
LinkedIn
ForwardSeries date:
09/29/2023 - 12:00pm EDT to 06/28/2024 - 1:00pm EDT
Disclosure of Relevant Financial Relationships
In accordance with the Standards for Integrity and Independence, GW requires all planners, faculty, and others in a position to control the educational content of an accredited CE activity to disclose the absence or existence of all financial relationships (of any dollar amount) with any ineligible companies within the past 24 months.
An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
GW reviews all disclosure statements to determine which financial relationships are relevant to the educational content of the CE activity. An individual is considered to have a relevant financial relationship if the educational content they can control is related to the business lines or products of the ineligible company.
Disclosure Statement(s)
Absence of Relevant Financial Relationships
None of the planners, faculty, staff, or others in a position to control the content of this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Planning Committee
Cyril Jacquot, MD (Activity Director)
Faculty
Title: Implementation of Bacterial WGS-Based Surveillance for Comprehensive Early Detection of Infection Transmission in a Pediatric Cancer Hospital
Speaker: Heather Glasgow, MD
Date: 09/29/2023 - 12:00pm to 1:00pm EDT
Title: Synthetic Biology Meets Bio-Inspired Engineering: Path to a Whole Blood Analogue for Austere Environments
Speaker: Allan Doctor, MD
Date: 10/27/2023 - 12:00pm to 1:00pm EDT
Title: Pediatric Tumor Diagnosis in the Precision Medicine Era: Progress and Challenges
Speaker: Lea Surrey
Date: 01/26/2024 - 12:00pm to 1:00pm EST
Title: Conventional and Unusual High-Grade Transformation of Low-Grade Lymphomas
Speaker: Tapan Bhavsar, MD, PhD
Date: 04/26/2024 - 12:00pm to 1:00pm EDT
Title: Pediatric Clinical Microbiology: Where "Weird" Infections in Little Ones Meet with Cutting-Edge Medical Laboratory Sciences/Technologies
Speaker: Benjamin Liu, MBBS, PhD, D(ABMM), MB(ASCP)
Date: 05/24/2024 - 12:00pm to 1:00pm EDT
Title: Update on Vascular Anomalies including ISSVA 2024 Meeting Highlights
Speaker: Harry Kozakewich, MD
Date: 07/26/2024 - 12:00pm to 1:00pm EDT
Title: From Farm to Fork to Physician: Understanding the Burden of Foodborne Disease
Speaker: Barbara Kowalcyk, PhD
Date: 10/11/2024 at 11:45 am – 12:45 pm EDT
Title: Traditional Methods and Future Trends in Antimicrobial Susceptibility Testing
Speaker: Stefan Riedel, MD
Date: 11/1/2024 at 12:00 – 1:00 pm EDT
Series location:
Children's National Hospital, Nulsen Conference Room + Zoom (hybrid)
111 Michigan Ave NW
Washington, DC
20010
United States
See map: Google Maps